Found "Health Policies": 1,061 results
Framework to guide the use of mathematical modelling in evidence-based policy decision-making
Abstract
Introduction The COVID-19 pandemic highlighted the significance of mathematical modelling in decision-making and the limited capacity in many low-income and middle-income countries (LMICs). Thus, we studied how modelling supported policy decision-making processes in LMICs during the pand
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
Abstract
Background and Objectives
The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m
DEFINING EARLY HEALTH TECHNOLOGY ASSESSMENT: BUILDING CONSENSUS USING DELPHI TECHNIQUE
In this paper we have reported a five-stage process, including a two-round Delphi survey that developed and reached consensus on a definition of early HTA, which is “a health technology assessment conducted to inform decisions about subsequent development, research and/or investment by explicitly ev
Economic Evaluation of Screening for Disease (2014)
Naiyana Praditsitthikorn BSc(Pharm), PhD*,**
* Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand
** Bureau of AIDS TB and STIs, Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand
There is an increasing number of at
Presentation of Economic Evaluation Results (2014)
Usa Chaikledkaew BSc(Pharm), MA, PhD*,**
* Social and Administrative Pharmacy Excellence Research (SAPER) Unit, Department of Pharmacy,
Faculty of Pharmacy, Mahidol University, Bangkok, Thailand
** Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thail
Thai Health Technology Assessment Guideline Development
Keywords: Health technology assessment, Rationale, Guideline development
Please follow the link below for full text. You may need to register (free-of-charge) as the article is published in Journal of the Medical Association of Thailand, Vol 91, No 6.
http://www.jmatonline.com/index.
A Retrospective Secondary Data Analysis of Telemedicine Service Utilization (2020-2023) Among Patients Covered By The Universal Coverage Scheme in Thailand
Abstract
Objective: The National Health Security Office in Thailand introduced a telemedicine program called “Telehealth/Telemedicine” in December 2020, which aimed to reimburse telemedicine services for patients with stable chronic diseases under the Universal Coverage Scheme (UCS). The current
Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
Abstract
Background and Objectives
The Health Intervention and Technology Assessment Program was commissioned to conduct a cost–utility and budget impact analysis of enzyme replacement therapy (ERT) for Gaucher disease types 1 and 3b. The findings from this assessment are to support the decision-m
Unveiling Thailand’s Path to Open Data for Health Policy
Open data is widely recognized as valuable, especially during the COVID-19 pandemic, highlighting the need for up-to-date information systems, leading all sectors to acknowledge its significance in enhancing efficiency, fairness, and societal development.
These open data movements observed during
The Trouble With ‘Doctor Knows Best’
Doctors were told last month that we should stop doing so many screenings for prostate cancer with the prostate-specific antigen test. We learned that sigmoidoscopy is a cheaper, easier and effective alternative to colonoscopy for colon cancer screening. And a study I led turned up strong evidence t
10 / Page